CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 4,3 · Q2 • database Scopus / SJR & Web of Science indexed
Drug Development Research
United States · John Wiley & Sons Inc.
workspace_premium Q2 — Drug Discovery lock_open Open Access

Drug Development Research

Drug Development Research is a journal indexed in SJR in Drug Discovery with an H index of 70. It has a price of 2950 €. It has a COP Index of 4,3 (best band Q2). It is published in English. It has a COP Index of 4,3.

Drug Development Research focuses its scope in these topics and keywords: heart, acetaminophen, induced, anhydrase, advances, channels, inhibitors, coadministration, isoproterenol, benzimidazole, ...

ISSN: 0272-4391
Publisher: John Wiley & Sons Inc.
Category: Drug Discovery
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
COP Index trending_up
4,3 Q2

36 of 128 journals in Drug Discovery

H-index · SJR 70 · 0,756
Acceptance rate pie_chart
28% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
2.950 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

4,3

Q2

SJR Impact

0,756

H-index

70

Docs (year)

161

Docs 3y

379

Total refs

9794

Cites 3y

1561

Citable 3y

363

Cites/Doc 2y

4.18

Ref/Doc

60.83

Immediate OA

2950 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the COP Index of Drug Development Research?

Drug Development Research has a COP Index of 4,3 (Q2), ranked 36 of 128 in Drug Discovery. SJR: 0,756.

What is the APC / publication cost?

Immediate OA APC is 2950 EUR. Non-OA / submission fee is 0 EUR.

What is the acceptance rate?

The acceptance rate recorded for Drug Development Research is 28%.